查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
生物標誌發現外包服務市場，按類型，按治療區域，按發現階段，按最終使用，按國家和地區 - 工業分析，市場規模，市場佔有率，市場佔有率和預測2023-2030
市場調查報告書
商品編碼
1388778

生物標誌發現外包服務市場，按類型，按治療區域，按發現階段，按最終使用，按國家和地區 - 工業分析，市場規模，市場佔有率，市場佔有率和預測2023-2030

Biomarker Discovery Outsourcing Services Market, By Type, By Therapeutic Area, By Discovery Phase, By End Use, By Country, and By Region -Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 311 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022年，生物標誌發現外包服務市場規模為 112.1 億美元，2023年至2030年複合CAGR為 23.5%。

生物標誌發現外包服務市場是更廣泛的製藥和生物技術領域中不斷成長的領域。生物標誌是分子或生物過程的量化指標，在疾病診斷、個人化醫療和藥物開發等領域有廣泛的應用。生物標誌發現外包服務提供專業知識和資源，幫助學術研究機構、製藥公司和其他組織驗證、利用和識別用於多種目的的生物標誌。

生物標誌發現外包服務市場-市場動態

慢性病盛行率上升推動市場成長

癌症、心血管疾病、神經退化性疾病和糖尿病等慢性疾病盛行率的增加是市場擴張的主要因素。此外，伴隨診斷的成長、對用於癌症檢測的液體活體組織切片的關注，以及使用機器學習和人工智慧進行資料分析，這些新興趨勢都刺激了市場的需求。此外，隨著個人化醫療變得更加普遍，以及對標靶治療和診斷工具的需求增加，因此，對生物標誌發現外包服務市場的需求預計將繼續成長。此外，生物標誌的發現是醫療保健和生命科學研究的重要組成部分。它有助於開發標靶療法、了解疾病機制以及疾病的早期檢測。這也導致對外包服務的需求不斷成長，以加快生物標誌研究。

生物標誌發現外包服務市場 - 關鍵見解

  • 根據研究分析師的分析，全球生物標誌發現外包服務市場預計在預測期內（2023-2030年）每年將以 23.5%左右的CAGR成長
  • 由於對個人化醫療的需求不斷成長，生物標誌發現外包服務產業預計將以顯著的速度成長
  • 根據類型細分，預計替代端點在2022年顯示最大的市場佔有率
  • 根據最終用途細分，生技公司是2022年的主導類型
  • 依地區分類，北美是2022年的主要收入來源。

生物標誌發現外包服務市場-細分分析：

全球生物標誌發現外包服務市場根據類型、治療領域、發現階段、最終用途和區域進行細分。

市場依類型分為四類：替代端點、預測生物標誌、安全生物標誌、預後生物標誌等。替代端點部分的成長率最高。為了實現疾病進展或患者存活等關鍵目標，臨床試驗可能需要數年時間並需要大量資源。替代生物標誌可以實現更有效率、更短的臨床試驗，因為它們可以提供治療效果的早期跡象，預計這些優勢將推動該領域的成長

根據最終用途，市場分為兩類：生技公司、製藥公司和其他。生技公司部門可能會在預測期內保持其主導地位。外包使生物技術公司能夠利用合約研究組織（CRO）等專業服務提供者的專業知識。與維護內部團隊、設備和基礎設施相比，外包生物標誌發現可能更具成本效益。生物技術公司可以透過致力於其核心競爭力（如治療研究或藥物開發）來更有效地分配資源。

生物標誌發現外包服務市場-地理洞察

按區域分析，生物標誌發現外包服務市場可分為北美、亞太地區、歐洲和世界其他地區。由於擁有創新技術、強大的生物技術產業、監管專業知識和先進的醫療基礎設施，北美可能會主導市場。在該地區，美國食品藥物管理局（FDA）和加拿大食品檢驗局（CFIA）等監管機構擁有著名的先進藥物和診斷生物標誌監管基礎設施。這種監管清晰度支持驗證工作和生物標誌研究。此外，預計亞太地區在預測期內將出現最大成長。在該地區，中國和印度等多個經濟體被視為生物技術和製藥的新興市場。對這些國家來說，外包生物標誌發現計畫的成本效益對全球製藥公司具有吸引力。

生物標誌發現外包服務市場-競爭格局：

該領域的企業通常提供從樣本採集到資料分析的廣泛服務，以滿足生物技術製藥客戶的多樣化需求。各種專業生物技術公司和合約研究組織（CRO）提供生物標誌發現服務。這些公司擁有代表客戶進行生物標誌相關研究和開發的基礎設施和專業知識。該市場受到蛋白質組學和基因組學技術進步的影響，這使得更全面的生物標誌發現成為可能。該領域的市場參與者採取多項策略性舉措，例如合作、夥伴關係和新產品發布，以維持其在市場上的業務立足點。

最近的發展：

2022年1月，Inotiv, Inc. 和Synexa Life Sciences 宣布，他們打算開展合作，加速Inotiv 生物標誌的開發，這些生物標誌對了解新型生物治療藥物的功效和安全性非常重要，並改善業務臨床前發現和安全性評估服務。

目錄

第1章 生物標誌發現外包服務市場概述

  • 研究範圍
  • 市場預估年份

第2章 執行摘要

  • 市場摘要
    • 依類型分類的生物標誌發現外包服務市場摘要
    • 依治療領域分類的生物標誌發現外包服務市場摘要
    • 按發現階段分類的生物標誌發現外包服務市場摘要
    • 依最終用途分類的生物標誌發現外包服務市場摘要
    • 依國家分類的生物標誌發現外包服務市場摘要
    • 依地區分類的生物標誌發現外包服務市場摘要
  • 競爭洞察

第3章 生物標誌發現外包服務主要市場趨勢

  • 生物標誌發現外包服務市場促進因素
    • 市場促進因素的影響分析
  • 生物標誌發現外包服務市場限制
    • 市場限制影響分析
  • 生物標誌發現外包服務市場機會
  • 生物標誌發現外包服務市場未來趨勢

第4章 生物標誌發現外包服務產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章 生物標誌發現外包服務市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第6章 生物標誌發現外包服務市場格局

  • 2022年生物標誌發現外包服務市場佔有率分析
  • 細分資料：按主要製造商
    • 既有參與者分析
    • 新興參與者分析

第7章 生物標誌發現外包服務市場 - 依類型

  • 概述
    • 依類型分類的細分市場佔有率分析
    • 替代終點
    • 預測性生物標誌
    • 安全生物標誌
    • 預後生物標誌
    • 其他

第8章 生物標誌發現外包服務市場 - 依治療領域

  • 概述
    • 依治療領域分類的細分市場佔有率分析
    • 自體免疫疾病
    • 腫瘤學
    • 心臟病學
    • 神經病學
    • 其他

第9章 生物標誌發現外包服務市場 - 按發現階段

  • 概述
    • 按發現階段分類的細分市佔率分析
    • 生物標誌選擇
    • 生物標誌鑑定
    • 生物標誌驗證
    • 生物標誌物組合開發
    • 生物標誌分析

第10章 生物標誌發現外包服務市場 - 依最終用途

  • 概述
    • 依最終用途分類的細分市場佔有率分析
    • 生技公司
    • 製藥公司
    • 其他

第11章 生物標誌發現外包服務市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 生物標誌發現外包服務北美主要製造商
    • 北美市場規模和預測（依國家）
    • 北美市場規模和預測（依類型）
    • 北美市場規模與預測（依治療領域）
    • 北美市場規模和預測（依發現階段）
    • 北美市場規模和預測（依最終用途）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 生物標誌發現外包服務歐洲主要製造商
    • 歐洲市場規模和預測（依國家）
    • 歐洲市場規模與預測（依類型）
    • 歐洲市場規模與預測（依治療領域）
    • 歐洲市場規模和預測（依發現階段）
    • 歐洲市場規模和預測（依最終用途）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區（APAC）
    • 概述
    • 生物標誌發現外包服務亞太地區主要製造商
    • 亞太地區市場規模與預測（依國家）
    • 亞太地區市場規模與預測（依類型）
    • 亞太地區市場規模和預測（依治療領域）
    • 亞太地區市場規模和預測（按發現階段）
    • 亞太地區市場規模和預測（依最終用途）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 生物標誌發現外包服務拉丁美洲主要製造商
    • 拉丁美洲市場規模與預測（依國家）
    • 拉丁美洲市場規模與預測（依類型）
    • 拉丁美洲市場規模與預測（依治療領域）
    • 拉丁美洲市場規模和預測（依發現階段）
    • 拉丁美洲市場規模和預測（依最終用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 生物標誌發現外包服務中東和非洲的主要製造商
    • 中東和非洲市場規模及預測（依國家）
    • 中東和非洲市場規模及預測（依類型）
    • 中東和非洲市場規模及預測（依治療領域）
    • 中東和非洲市場規模和預測（依發現階段）
    • 中東和非洲市場規模和預測（依最終用途）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第12章 主要供應商分析 - 生物標誌發現外包服務產業

  • 競爭儀表板
  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • Laboratory Corporation of America Holdings
    • GHO Capital
    • ICON plc
    • Agilent
    • Proteome Sciences
    • Charles River Laboratories.
    • Eurofins Scientific
    • Celerion
    • Evotec
    • Parexel International（MA）Corporation

第13章 360 度分析師視角

第14章 附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV1840

REPORT HIGHLIGHT

Biomarker discovery outsourcing services market size was valued at USD 11,210 Million in 2022, expanding at a CAGR of 23.5% from 2023 to 2030.

The biomarker discovery outsourcing services market is a growing sector within the broader pharmaceutical and biotechnology sector. Biomarkers are quantifiable indicators of molecular or biological processes with a wide range of applications in areas including disease diagnosis, personalized medicine, and drug development. Biomarker discovery outsourcing services provide specialized expertise and resources to help academic research institutions, pharmaceutical companies, and other organizations validate, utilize, and identify biomarkers for several purposes.

Biomarker Discovery Outsourcing Services Market- Market Dynamics

The rising prevalence of chronic diseases is propelling market growth

The increase in the prevalence of chronic diseases including cancer, cardiovascular diseases, neurodegenerative conditions, and diabetes are major contributing factors to the market expansion. Additionally, the growth of companion diagnostics, a focus on liquid biopsy for cancer detection, and the use of machine learning and artificial intelligence for data analysis are emerging trends fueling the demand of the market. Moreover, as personalized medicine becomes more prevalent and as the demand for targeted therapies and diagnostic tools increases, thus, the demand for biomarker discovery outsourcing services market is expected to continue growing. Furthermore, biomarker discovery is a crucial component of healthcare and life sciences research. It aids in developing targeted therapies, understanding disease mechanisms, and the early detection of diseases. This also led to a rising demand for outsourcing services to expedite biomarker research.

Biomarker Discovery Outsourcing Services Market- Key Insights

  • As per the analysis shared by our research analyst, the global biomarker discovery outsourcing services market is estimated to grow annually at a CAGR of around 23.5% over the forecast period (2023-2030)
  • The biomarker discovery outsourcing services industry is projected to grow at a significant rate due to the growing demand for personalized medicine
  • Based on type segmentation, surrogate endpoints was predicted to show maximum market share in the year 2022
  • Based on end use segmentation, biotechnology companies was the leading type in 2022
  • Based on Region, North America was the leading revenue generator in 2022.

Biomarker Discovery Outsourcing Services Market- Segmentation Analysis:

The global biomarker discovery outsourcing services market is segmented on the basis of type, therapeutic area, discovery phase, end use, and region.

The market is divided into four categories based on type: surrogate endpoints, predictive biomarkers, safety biomarkers, prognostic biomarkers, and others. The surrogate endpoints segment is accounted to witness the highest growth rate. To accomplish crucial objectives such as disease progression or patient survival, clinical trials can take years and need substantial resources. Surrogate biomarkers enables for more efficient and shorter clinical trials because they can offer early indications of treatment efficacy, such advantages are projected to drive the segment's growth

The market is divided into two categories based on end use: biotechnology companies, pharmaceutical companies, and others. The biotechnology companies segment is likely to maintain its dominance over the forecast period. Outsourcing enables biotechnology companies to tap into the expertise of specialized service providers, such as Contract Research Organizations (CROs). Outsourcing biomarker discovery might be cost-effective over maintaining in-house teams, equipment, and infrastructure. Biotechnology companies can allocate resources more effectively by focusing on their core competencies, like therapeutic research or drug development.

Biomarker Discovery Outsourcing Services Market- Geographical Insights

By regional analysis, the biomarker discovery outsourcing services market can be segmented into North America, Asia Pacific, Europe, and the Rest of the World. North America is likely to dominate the market due to its access to innovating technologies, robust biotech industry, regulatory expertise, and advanced healthcare infrastructure. In the region, regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the Canadian Food Inspection Agency (CFIA), have renowned regulatory infrastructure for biomarkers in advanced drugs and diagnostics. This regulatory clarity supports validation efforts and biomarker research. Furthermore, Asia Pacific is anticipated to witness maximum growth during the forecast period. In the region, various economies such as China and India are considered emerging markets for biotechnology and pharmaceuticals. To these countries, the cost-effectiveness of outsourcing biomarker discovery projects can be attractive to worldwide pharmaceutical business.

Biomarker Discovery Outsourcing Services Market- Competitive Landscape:

Businesses in this space typically provide a vast range of services, from sample collection to data analysis, to meet the diverse needs of biotechnology pharmaceutical clients. Various specialized biotechnology companies and contract research organizations (CROs) offer biomarker discovery services. These companies have the infrastructure and expertise to carry out biomarker-related research and development on behalf of their clients. The market is influenced by the advancement of technology in proteomics and genomics which allow more comprehensive biomarker discovery. Market players operating in this sector are adopting several strategic initiatives, such as collaborations, partnerships, and new product launches, to maintain their business foothold in the market.

Recent Developments:

In January 2022, Inotiv, Inc. and Synexa Life Sciences announced that they intend to form a collaboration that will accelerate Inotiv's development of biomarkers important to the understanding of efficacy and safety of novel biotherapeutics, improve the business preclinical discovery and safety assessment services.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET KEY PLAYERS

  • Thermo Fisher Scientific Inc.
  • Laboratory Corporation of America Holdings
  • GHO Capital
  • ICON plc
  • Agilent
  • Proteome Sciences
  • Charles River Laboratories.
  • Eurofins Scientific
  • Celerion
  • Evotec
  • Parexel International (MA) Corporation

GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET, BY TYPE

  • Surrogate endpoints
  • Predictive biomarkers
  • Safety biomarkers
  • Prognostic biomarkers
  • Others

GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET, BY THERAPEUTIC AREA

  • Autoimmune Diseases
  • Oncology
  • Cardiology
  • Neurology
  • Others

GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET, BY DISCOVERY PHASE

  • Biomarker Selection
  • Biomarker Identification
  • Biomarker Validation
  • Biomarker Panel Development
  • Biomarker Profiling

GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET, BY END USE

  • Biotechnology Companies
  • Pharmaceutical Companies
  • Others

GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Biomarker Discovery Outsourcing Services Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Biomarker Discovery Outsourcing Services Market Snippet by Type
    • 2.1.2. Biomarker Discovery Outsourcing Services Market Snippet by Therapeutic Area
    • 2.1.3. Biomarker Discovery Outsourcing Services Market Snippet by Discovery Phase
    • 2.1.4. Biomarker Discovery Outsourcing Services Market Snippet by End Use
    • 2.1.5. Biomarker Discovery Outsourcing Services Market Snippet by Country
    • 2.1.6. Biomarker Discovery Outsourcing Services Market Snippet by Region
  • 2.2. Competitive Insights

3. Biomarker Discovery Outsourcing Services Key Market Trends

  • 3.1. Biomarker Discovery Outsourcing Services Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Biomarker Discovery Outsourcing Services Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Biomarker Discovery Outsourcing Services Market Opportunities
  • 3.4. Biomarker Discovery Outsourcing Services Market Future Trends

4. Biomarker Discovery Outsourcing Services Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Biomarker Discovery Outsourcing Services Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Biomarker Discovery Outsourcing Services Market Landscape

  • 6.1. Biomarker Discovery Outsourcing Services Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Biomarker Discovery Outsourcing Services Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022&2030 (%)
    • 7.1.2. Surrogate endpoints
    • 7.1.3. Predictive biomarkers
    • 7.1.4. Safety biomarkers
    • 7.1.5. Prognostic biomarkers
    • 7.1.6. Others

8. Biomarker Discovery Outsourcing Services Market - By Therapeutic Area

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Therapeutic Area, 2022&2030 (%)
    • 8.1.2. Autoimmune Diseases
    • 8.1.3. Oncology
    • 8.1.4. Cardiology
    • 8.1.5. Neurology
    • 8.1.6. Others

9. Biomarker Discovery Outsourcing Services Market - By Discovery Phase

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Discovery Phase, 2022&2030 (%)
    • 9.1.2. Biomarker Selection
    • 9.1.3. Biomarker Identification
    • 9.1.4. Biomarker Validation
    • 9.1.5. Biomarker Panel Development
    • 9.1.6. Biomarker Profiling

10. Biomarker Discovery Outsourcing Services Market - By End Use

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End Use, 2022&2030 (%)
    • 10.1.2. Biotechnology Companies
    • 10.1.3. Pharmaceutical Companies
    • 10.1.4. Others

11. Biomarker Discovery Outsourcing Services Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Biomarker Discovery Outsourcing Services Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Biomarker Discovery Outsourcing Services Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Biomarker Discovery Outsourcing Services Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Biomarker Discovery Outsourcing Services Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Biomarker Discovery Outsourcing Services Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Biomarker Discovery Outsourcing Services Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Thermo Fisher Scientific Inc.
    • 12.2.2. Laboratory Corporation of America Holdings
    • 12.2.3. GHO Capital
    • 12.2.4. ICON plc
    • 12.2.5. Agilent
    • 12.2.6. Proteome Sciences
    • 12.2.7. Charles River Laboratories.
    • 12.2.8. Eurofins Scientific
    • 12.2.9. Celerion
    • 12.2.10. Evotec
    • 12.2.11. Parexel International (MA) Corporation

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Biomarker Discovery Outsourcing Services Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Biomarker Discovery Outsourcing Services Market, by Type2018-2030 (USD Million)
  • TABLE Biomarker Discovery Outsourcing Services Market: Therapeutic AreaSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Therapeutic Area
  • TABLE Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area2018-2030 (USD Million)
  • TABLE Biomarker Discovery Outsourcing Services Market: Discovery Phase Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Discovery Phase
  • TABLE Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase 2018-2030 (USD Million)
  • TABLE Biomarker Discovery Outsourcing Services Market: End Use Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End Use
  • TABLE Global Biomarker Discovery Outsourcing Services Market, by End Use 2018-2030 (USD Million)
  • TABLE Biomarker Discovery Outsourcing Services Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Biomarker Discovery Outsourcing Services Market, by Region 2018-2030 (USD Million)
  • TABLE North America Biomarker Discovery Outsourcing Services Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Biomarker Discovery Outsourcing Services Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
  • TABLE North America Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
  • TABLE North America Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
  • TABLE Europe Biomarker Discovery Outsourcing Services Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Biomarker Discovery Outsourcing Services Market, by Type, 2018-2030 (USD Million)
  • TABLE EuropeBiomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
  • TABLE EuropeBiomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
  • TABLE EuropeBiomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biomarker Discovery Outsourcing Services Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biomarker Discovery Outsourcing Services Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
  • TABLE Latin America Biomarker Discovery Outsourcing Services Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Biomarker Discovery Outsourcing Services Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
  • TABLE Latin America Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
  • TABLE Latin America Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biomarker Discovery Outsourcing Services Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biomarker Discovery Outsourcing Services Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)